Metagenomi, Inc Common Stock

Yahoo Finance • 8 days ago

MGX joins Silver Lake as co-investor in semiconductor company Altera

MGX, a United Arab Emirates-based investor in AI and advanced technologies, has joined Silver Lake as a co-investor in acquiring a 51% stake in Altera. Based in California, US, Altera specialises in programmable semiconductor solutions.... Full story

Yahoo Finance • 17 days ago

Databricks projects $4 billion in annual revenue on surging AI demand

(Reuters) -Analytics firm Databricks (DATB.PVT) was on track to hit $4 billion in annual revenue, up more than 50% from the prior year, on the back of surging demand for its AI products. In the second quarter, the company serving around 1... Full story

Yahoo Finance • last month

Earnings call transcript: Mount Gibson Iron Q4 2025 highlights strategic shift

Mount Gibson Iron Ltd (MGX) reported its Q4 2025 earnings, showcasing a strategic pivot towards diversification and growth despite the absence of earnings forecasts. The company’s shares rose by 5.33% following the earnings call, closing a... Full story

Yahoo Finance • last month

Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

METAGENOMI INC (NASDAQ:MGX [https://www.chartmill.com/stock/quote/MGX]) REPORTS Q2 2025 EARNINGS: REVENUE BEATS ESTIMATES, LOSS NARROWS Metagenomi Inc, a precision genetic medicines company, reported its second-quarter 2025 financial resu... Full story

Yahoo Finance • 2 months ago

Metagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting

Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced the presentation of 3 abstracts at the American Society of Gene & Cell Therapy/ASGCT 28th Annual Meeting, which was... Full story

Yahoo Finance • 2 months ago

3 Penny Stocks With Market Caps Over $80M To Watch Closely

The U.S. stock market has been navigating a wave of uncertainty, with recent tariff threats from President Trump causing fluctuations across major indices such as the Dow Jones, S&P 500, and Nasdaq. Amid these broader market dynamics, penn... Full story

Yahoo Finance • 4 months ago

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate the ability to speci... Full story

Yahoo Finance • 4 months ago

Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

- Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately 19 months with an encouraging safety profile - Well capitalized with $226.0 mill... Full story

Yahoo Finance • 6 months ago

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A albumin platform to a... Full story

Yahoo Finance • 6 months ago

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Achieved targeted integration of a large, therapeutically relevant gene into the genome of human cells with compact CAST system AI-driven metagenomics platform facilitated discovery of CAST system with activity in human cells Expression... Full story

Yahoo Finance • 7 months ago

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

EMERYVILLE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today anno... Full story

Yahoo Finance • 8 months ago

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Ha... Full story